I’ve taken the liberty of a week’s break and am ready to get back to blogging again. The high point of the week was an excellent performance of Turandot at Kennedy Center yesterday evening. My weakness for Puccini stems from early imprinting from my neuroscientist parents, who were as interested in classical music as anything except the brain itself.
Author: jlolds
Markoff on the new AI
The NY Times’ John Markoff sees AI as emerging from its “caution flag” state that it entered in the mid-1980’s.
“I see the debate over whether we should build these artificial intellects as becoming the dominant political question of the century,” said Hugo de Garis, an Australian artificial-intelligence researcher, who has written a book, “The Artilect War,” that argues that the debate is likely to end in global war.
NIH to the rescue on the drug pipeline
ScienceInsider reports on NIH’s new initiative to develop drugs for orphan diseases. Money quote:
NIH leaders today announced a $120 million, 5-year plan to set up a drug development service center at the agency. The center’s chemists and toxicologists will modify promising compounds until they’re ready to be tested in people. The focus will be on rare and neglected diseases.
Robotics taken to the next level….
Real Time DT MRI fiber tracing
Science reporting
Here in Washington, we wake up to WTOP, the local all-news station. This morning, substantially before I had my coffee, I thought I heard the mention of a new clinical study (I wont mention the results here) for which the conclusions sounded really hard to believe. Of course there was no context at all, no mention of where the study was published and therefore no chance of critically evaluating the conclusions.
Wolfram Alpha
It’s coming on-line at 8PM EST this evening. But the preview narrated by Stephan Wolfram himself blew me away. It’s definitely qualitatively different from Google.
Charles Bolden to head NASA?
Politico says that former astronaut Charles Bolden is going to be the pick for NASA administrator. That suggests to me that manned space flight is still going to be in the mix.
Give them an inch….
From today’s SCIENCE magazine:
A frantic grant-writing effort that has consumed biomedical research scientists this spring came to an end last week, resulting in a huge pile of new applications—more than 10 times larger than expected—to be reviewed by the National Institutes of Health (NIH). After this enthusiastic response, there will be many disappointed applicants: The rejection rate could run as high as 98%.
Mason Commencement 2009
Tomorrow morning, I’ll get up early and drive from Arlington to the Fairfax campus. I’ll park at the Institute and walk across the Mason campus in my University of Michigan academic regalia –FYI the trademark “M” isn’t a part of the get up–to join with colleagues at the Patriot Center, putting a full stop on the academic year that began last August. Commencement paradoxically derives from the verb to commence, but ends the academic year rather than beginning it. To my mind, that’s because commencement exercises aren’t about the faculty or the deans, but rather about the graduating students, who now are about to commence their post-degree lives.